Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 16, 2011 - Issue 1
Submit an article Journal homepage
243
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for Waldenström's macroglobulinemia

Efstathios Kastritis University of Athens School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, 115 28, Athens, Greece + 30210 3381541; + 30210 3381511; [email protected]
, MD,
Evangelos Terpos University of Athens School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, 115 28, Athens, Greece + 30210 3381541; + 30210 3381511; [email protected]
, MD &
Meletios A Dimopoulos University of Athens School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, 115 28, Athens, Greece + 30210 3381541; + 30210 3381511; [email protected]
, MD
Pages 45-57 | Published online: 25 Feb 2011

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2017) Current treatment options and investigational drugs for Waldenstrom’s Macroglobulinemia. Expert Opinion on Investigational Drugs 26:2, pages 197-205.
Read now
Rajshekhar Chakraborty, Stephen A Ansell, Prashant Kapoor & Morie A Gertz. (2015) Phase II clinical trials for Waldenstrom’s macroglobulinemia. Expert Opinion on Orphan Drugs 3:5, pages 537-547.
Read now
Morie A Gertz. (2012) Waldenström macroglobulinemia. Hematology 17:sup1, pages s112-s116.
Read now

Articles from other publishers (2)

M.A. Dimopoulos, E. Kastritis & I.M. Ghobrial. (2016) Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics. Annals of Oncology 27:2, pages 233-240.
Crossref
Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Denise Niewerth, Johan van Meerloo, Jacqueline Cloos, Michael van der Veer, George L Scheffer, Godefridus J Peters, Elena T Chan, Janet L Anderl, Christopher J Kirk, Sonja Zweegman, Ben AC Dijkmans, Willem F Lems, Rik J Scheper, Tanja D de Gruijl & Gerrit Jansen. (2013) Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors. Experimental Hematology & Oncology 2:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.